The medical aid group—Doctors without Borders—warns that drug-resistant tuberculosis has become a global threat. It says despite the growing number of cases, there are no effective treatments. View external media.
The Food and Drug Administration has granted accelerated approval for bedaquiline, the first tuberculosis drug to be developed in 40 years. Bedaquiline is "a potential game changer" in treating drug-resistant tuberculosis, according to Dr. Manica Balasegaram, executive director of MSF's Access Campaign.